KimJSAvilesDHSilversteinDMLeblancPLMatti VehaskariV
The community has faced relentless barriers to accessing GLP-1 medications, which has ultimately come down to the price, despite the data we have supporting their effectiveness. Murphy, Madhani and Aleccia write for the Associated Press.
PlexusDx providers can discuss personalized discontinuation strategies during your treatment
Hormonal change is at the root of dozens of symptoms women experience in the years before and after their period stops
Our approach is to evaluate each patient individually and provide guidance based on their complete health picture
In the SUSTAIN clinical trial program, Ozempic produced superior reductions in HbA1c (long-term blood sugar) compared to placebo, sitagliptin, exenatide, insulin glargine, and dulaglutide